US2012203323A1PendingUtilityA1

Method and system for delivery of coated implants

Individually held — no corporate assignee on recordPriority: Apr 27, 2001Filed: Apr 2, 2012Published: Aug 9, 2012
Est. expiryApr 27, 2021(expired)· nominal 20-yr term from priority
A61L 29/085A61F 2210/0004A61F 2/82A61L 29/14A61F 2250/0067
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An implant delivery system comprises an implant delivery device having a releasable implant retention region, with the releasable implant retention region having a delivery device coating including a therapeutic agent. The implant delivery device may be a balloon catheter. An implant is releasably positioned in physical communication with the releasable implant retention region. The implant may comprise an implant coating on its inner and/or outer surface, and the implant coating may include a therapeutic agent. The implant may be a stent.

Claims

exact text as granted — not AI-modified
1 .- 23 . (canceled) 
     
     
         24 . An implant delivery system comprising:
 an implant delivery device having a distal end with a releasable implant retention region, the releasable implant retention region having an outer surface comprising a delivery device coating, said delivery device coating including a therapeutic agent; and   a releasable implant releasably positioned in physical communication with the releasable implant retention region.   
     
     
         25 . The implant delivery system of  claim 24  wherein the implant comprises an implant coating. 
     
     
         26 . The implant delivery system of  claim 25  wherein the implant coating is positioned on an inner surface of the implant. 
     
     
         27 . The implant delivery system of  claim 26  wherein the implant coating includes a therapeutic agent. 
     
     
         28 . The implant delivery system of  claim 27  wherein the therapeutic agent comprises a vascular cell growth promoter. 
     
     
         29 . The implant delivery system of  claim 25  wherein the implant coating is positioned on an outer surface of the implant. 
     
     
         30 . The implant delivery system of  claim 29  wherein the implant coating includes a therapeutic agent. 
     
     
         31 . The implant delivery system of  claim 30  wherein the therapeutic agent comprises an antiproliferative agent. 
     
     
         32 . The implant delivery system of  claim 25  wherein the implant coating is positioned on an inner surface and an outer surface of the implant. 
     
     
         33 . The implant delivery system of  claim 32  wherein the implant coating includes a therapeutic agent. 
     
     
         34 . The implant delivery system of  claim 24  wherein the implant delivery device is a balloon catheter. 
     
     
         35 . The implant delivery system of  claim 24  wherein the delivery device coating comprises an implant adhesion-resistant treatment. 
     
     
         36 . The implant delivery system of  claim 35  wherein the implant adhesion-resistant treatment includes a non-adhesive silicone coating. 
     
     
         37 . The implant delivery system of  claim 35  wherein the implant adhesion-resistant treatment includes a non-adhesive hydrophilic coating. 
     
     
         38 . The implant delivery system of  claim 35  wherein the implant adhesion-resistant treatment includes a non-adhesive hydrogel coating. 
     
     
         39 . The implant delivery system of  claim 35  wherein the implant adhesion-resistant treatment includes a non-adhesive carbowax coating. 
     
     
         40 . The implant delivery system of  claim 35  wherein the implant adhesion-resistant treatment includes a non-adhesive PEO coating. 
     
     
         41 . The implant delivery system of  claim 24  wherein the implant is a balloon-expandable stent. 
     
     
         42 . The implant delivery system of  claim 24  wherein the implant is a self-expanding stent. 
     
     
         43 . The implant delivery system of  claim 24  wherein said releasable implant retention region extends along an entire length of the implant.

Join the waitlist — get patent alerts

Track US2012203323A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.